292 related articles for article (PubMed ID: 18845274)
1. Patient perception of generic antiepileptic drugs in the Midwestern United States.
Papsdorf TB; Ablah E; Ram S; Sadler T; Liow K
Epilepsy Behav; 2009 Jan; 14(1):150-3. PubMed ID: 18845274
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic equivalency of generic antiepileptic drugs: results of a survey.
Wilner AN
Epilepsy Behav; 2004 Dec; 5(6):995-8. PubMed ID: 15582850
[TBL] [Abstract][Full Text] [Related]
3. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
[TBL] [Abstract][Full Text] [Related]
4. Generic substitution in the treatment of epilepsy: patient and physician perceptions.
Berg MJ; Gross RA; Haskins LS; Zingaro WM; Tomaszewski KJ
Epilepsy Behav; 2008 Nov; 13(4):693-9. PubMed ID: 18589000
[TBL] [Abstract][Full Text] [Related]
5. Generic products of antiepileptic drugs (AEDs): is it an issue?
Bialer M
Epilepsia; 2007 Oct; 48(10):1825-32. PubMed ID: 17850324
[TBL] [Abstract][Full Text] [Related]
6. Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsy.
Haskins LS; Tomaszewski KJ; Crawford P
Epilepsy Behav; 2005 Aug; 7(1):98-105. PubMed ID: 15961350
[TBL] [Abstract][Full Text] [Related]
7. The use of generic medication in epilepsy: a review of potential issues and challenges.
Van Paesschen W; Hauman H; Lagae L
Eur J Paediatr Neurol; 2009 Mar; 13(2):87-92. PubMed ID: 18790656
[TBL] [Abstract][Full Text] [Related]
8. An assessment of patient and pharmacist knowledge of and attitudes toward reporting adverse drug events due to formulation switching in patients with epilepsy.
McAuley JW; Chen AY; Elliott JO; Shneker BF
Epilepsy Behav; 2009 Jan; 14(1):113-7. PubMed ID: 18768168
[TBL] [Abstract][Full Text] [Related]
9. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.
Andermann F; Duh MS; Gosselin A; Paradis PE
Epilepsia; 2007 Mar; 48(3):464-9. PubMed ID: 17346246
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with poor seizure control and increased side effects after switching to generic antiepileptic drugs.
Bautista RE; Gonzales W; Jain D
Epilepsy Res; 2011 Jun; 95(1-2):158-67. PubMed ID: 21530177
[TBL] [Abstract][Full Text] [Related]
11. Prescribing generic antiepileptic drugs: Issues and concerns for nurse practitioners.
Barrett MW
J Am Acad Nurse Pract; 2010 Jun; 22(6):300-4. PubMed ID: 20536627
[TBL] [Abstract][Full Text] [Related]
12. Economic burden associated with the use of generic antiepileptic drugs in the United States.
Helmers SL; Paradis PE; Manjunath R; Duh MS; Lafeuille MH; Latrémouille-Viau D; Lefebvre P; Labiner DM
Epilepsy Behav; 2010 Aug; 18(4):437-44. PubMed ID: 20580619
[TBL] [Abstract][Full Text] [Related]
13. Case-control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes.
Zachry WM; Doan QD; Clewell JD; Smith BJ
Epilepsia; 2009 Mar; 50(3):493-500. PubMed ID: 18616554
[TBL] [Abstract][Full Text] [Related]
14. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
Perucca E; Albani F; Capovilla G; Bernardina BD; Michelucci R; Zaccara G
Epilepsia; 2006; 47 Suppl 5():16-20. PubMed ID: 17239100
[TBL] [Abstract][Full Text] [Related]
15. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
[TBL] [Abstract][Full Text] [Related]
16. Association between antiepileptic drug switching and epilepsy-related events.
Hansen RN; Campbell JD; Sullivan SD
Epilepsy Behav; 2009 Aug; 15(4):481-5. PubMed ID: 19615948
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy.
Erickson SC; Le L; Ramsey SD; Solow BK; Zakharyan A; Stockl KM; Harada AS; Curtis B
Epilepsia; 2011 Jul; 52(7):1365-71. PubMed ID: 21692778
[TBL] [Abstract][Full Text] [Related]
18. Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.
LeLorier J; Duh MS; Paradis PE; Lefebvre P; Weiner J; Manjunath R; Sheehy O
Neurology; 2008 May; 70(22 Pt 2):2179-86. PubMed ID: 18505997
[TBL] [Abstract][Full Text] [Related]
19. Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population.
Landmark CJ; Fossmark H; Larsson PG; Rytter E; Johannessen SI
Epilepsy Res; 2011 Jun; 95(1-2):51-9. PubMed ID: 21435840
[TBL] [Abstract][Full Text] [Related]
20. [The clinical and economic impact of generic drugs in the treatment of epilepsy].
Argumosa A; Herranz JL
Rev Neurol; 2005 Jul 1-15; 41(1):45-9. PubMed ID: 15999330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
